In this episode we kick off the next chapter of the DTx podcast. We heard you loud and clear - this industry is here to stay and therefore we are moving away from Seasons and going Evergreen - so what does that mean for you? It means we will continue bringing you deep conversations and knowledge from trailblazers, policy makers, associations and of course patients and health consumers. Chandana Fitzgerald, CEO of HealthXL has agreed to continue being my partner on this podcast asking the tough questions and dive into a short recap of last year’s DTx news but also what we are seeing as some of the key trends emerging into 2023 and beyond.   In this episode, we cover: How digital therapeutics have evolved and the future of DTx The Access to Prescription Digital Therapeutics Act of 2022  Digital Therapeutic Alliance approaches to evidence generation and upcoming conferences  Scaling DTx Pharmacy Benefits Management systems Navigating Sick care vs Healthcare And much more! Guest Links and Resources: Chandana Fitzgerald on LinkedIn Visit HealthXL Host Links: Eugene Borukhovich: Twitter | LinkedIn Chandana Fitzgerald, MD: Twitter | LinkedIn YourCoach.health: Website | Twitter Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Digital Health Today and the DTx Podcast would not be possible without the support of leading organizations. Thank you to: • Presenting Partner: Amalgam Rx • Sponsors: Akili • Big Health • Click Therapeutics • Lindus Health Follow Digital Health Today: Browse Episodes • Twitter • LinkedIn • Facebook • Instagram Follow Health Podcast Network: Browse Shows • LinkedIn • Twitter • Facebook • Instagram

In this episode, we hear from Louisa Stuwe & Aymeric Perchant, eHealth projects directors at the French Ministry of Health. For those who follow this podcast and the digital therapeutics industry, you know that all eyes have been on Germany with the DiGA. Well by popular demand, I have the pleasure of hosting Louisa and Aymeric to give YOU, our audience, a bit of history and the current state of digital therapeutics in France. In this episode, we cover: The digital health journey at the Ministry of Health DTx Reinbursement and Evidence Generation Physician education and adoption Lessons learned from Germany and DiGA The role of doctors, nurse & pharmacists in prescription DTx Guest Links and Resources: Connect with Louisa Stüwe on LinkedIn Connect with Aymeric Perchant on LinkedIn HTA Agency: https://www.has-sante.fr/ National Digital Health Agency : https://esante.gouv.fr/ Convergence platform: File document for interop & security certification + GDPR : https://convergence.esante.gouv.fr/ Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to: > Presenting Partner: Amalgam Rx > Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram

In this episode, we hear from Shailja Dixit, CEO of Curio. In their own words: 'Curio is a Digital Therapeutics company with tailor-made Cognitive Behavioral Therapy programs for Women across the cycle of life – encompassing age groups, physiological conditions and social settings'. Topics include: The Founding Story of Curio Using Digital to Destigmatize Mental Health Support User experience of the MamaLift product Combining methods of Cognitive Behavioural Therapy, Interpersonal Therapy and Behavioural Activation Therapy  PDT vs Physician recommended DTx  Guest Links and Resources: Connect with Shailja Dixit on LinkedIn Visit https://www.curiodigitaltx.com/ Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to: > Presenting Partner: Amalgam Rx > Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram

In this episode, we hear from Dominik Burziwoda, CEO and Co-Founder of Perfood. Perfood, in their own words is working on a pipeline of 'prescription digital therapeutics powered by personalized nutrition'. In this episode, we cover: The background and creation of Perfood The digital health scene in Germany Consumer experience of Perfood The process of DiGA approval and commercialisation Guest Links and Resources: Connect with Dominik Burziwoda on LinkedIn Visit https://perfood.de/ Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to: > Presenting Partner: Amalgam Rx > Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram

In this episode, we hear from Clara Campàs, Managing Partner and Co-Founder at Asabys Partners. Asabys Partners is an venture fund based in Barcelona, Spain investing in healthcare and life sciences innovation. In this episode, we cover: The healthcare thesis at Asabys Ventures Stand-alone DTx (biotech-like pipelines) vs. Drug+ DTx + Approaching valuations and investments when entering the DTx space Drivers for new capital injections in DTx in the last 2 years Scaling digital therapeutics in Europe Guest Links and Resources: Connect with Clara Campàs on LinkedIn Visit https://asabys.com/ Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to: > Presenting Partner: Amalgam Rx > Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram

In this coffee talk with AmalgamRX we dive into the challenges being faced by health systems as they work to assess, develop, and implement solutions at the time of a clinical decision. We'll explore the major pain points that keep projects from reaching their full potential, what it takes to overcome these challenges and what you can do when you're developing a digital therapeutic solution for your organization. There's also some tips that apply to payers and pharma as they play a key role in the successful development and implementation of digital therapies. Guest Links and Resources: Connect with Jenni Main on LinkedIn Connect with Dr. Suzanne Clough on LinkedIn Visit https://amalgamrx.com/ Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to: > Presenting Partner: Amalgam Rx Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram

In this episode, we hear from Sammeli Liikkanen, Digital Medicines Director at Orion Corporation. Orion Pharma is a globally operating Finnish pharmaceutical company with core therapy areas of neurological disorders, oncology, Finnish heritage rare diseases and respiratory diseases. In this episode, we cover: How Orion approaches non-molecular innovation Solving misconceptions in digital medicine VR as a modality for DTx Patient experience using VR Approaches to evidence generation Commercializing stand alone DTx vs Drug+ Guest Links and Resources: Connect with Sammeli Liikkanen on LinkedIn Visit https://www.orion.fi/en/ Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to: > Presenting Partner: Amalgam Rx > Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram

In this episode we hear from Sai Shankar, President of the Digital Health Unit at Aptar Pharma. Aptar Pharma provides drug delivery systems, active material science solutions and services globally- some products include: nasal spray pumps, MDI valves, dose indicators & counters, DPIs, electronic / connected devices, eye-droppers, elastomeric components (for injectable delivery devices), and more! In this episode, we cover: The background to AptarGroup, Aptar Pharma and its acquisition of Voluntis How the Aptar digital health unit came about Rationale behind the acquisition of Cohero Health Bringing together teams and lessons learned in integration processes Drug+ and key go-to-market opportunities Evidence generation and life sciences partner What is next for the digital health unit at Aptar Pharma? Guest Links and Resources: Connect with Sai Shankar on LinkedIn Visit: https://www.aptar.com/ Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to: > Presenting Partner: Amalgam Rx > Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram